Trials / Completed
CompletedNCT01822977
The Impact of Proton Pump Inhibitors on the Fecal Microbiome
The Impact of Proton Pump Inhibitors on the Fecal Microbiome and Their Relationship to Clostridium Difficile Infection
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The investigators hypothesis is that daily use of a proton pump inhibitor (PPI) is associated with significant alterations in the healthy fecal microbiome that are similar to those seen in persons with an initial episode of clostridium difficile infection (CDI).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | omeprazole |
Timeline
- Start date
- 2013-03-01
- Primary completion
- 2013-12-01
- Completion
- 2013-12-01
- First posted
- 2013-04-04
- Last updated
- 2014-08-20
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01822977. Inclusion in this directory is not an endorsement.